
You can purchase shares of Yarrow Bioscience (NASDAQ:YARW) through any online brokerage.
Other companies in Yarrow Bioscience’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Yarrow Bioscience has a consensus price target of $59.00.
The stock price for Yarrow Bioscience (NASDAQ: YARW) is $13.4 last updated November 5, 2026 at 7:20 PM EST.
There are no upcoming dividends for Yarrow Bioscience.
Yarrow Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Yarrow Bioscience.
Yarrow Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting...